| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/11/2003 | WO2003038037A3 Glycogen synthase kinase function in endothelial cells |
| 12/11/2003 | WO2003037166A3 Devices and methods for the restoration of a spinal disc |
| 12/11/2003 | WO2003034996A3 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 12/11/2003 | WO2003029292A3 Gene regulatory peptides |
| 12/11/2003 | WO2003028721A3 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 12/11/2003 | WO2003026564A3 Pharmaceutical compositions for the treatment of urinary disorders |
| 12/11/2003 | WO2003024958A3 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles |
| 12/11/2003 | WO2003024926A3 Methods and compositions of novel triazine compounds |
| 12/11/2003 | WO2003022216A3 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 12/11/2003 | WO2003017940A3 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 12/11/2003 | WO2003000719A3 Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same |
| 12/11/2003 | WO2002094176A3 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments |
| 12/11/2003 | WO2002092552A3 Benzamidoacetonitriles and their use as antiparasitics |
| 12/11/2003 | WO2002089791A3 Acne treatment with lipooxigenase inhibitors |
| 12/11/2003 | WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 12/11/2003 | WO2002087465A3 Compositions and methods of double-targeting virus infections and cancer cells |
| 12/11/2003 | WO2002083067A3 Prodrugs via acylation with cinnamate |
| 12/11/2003 | WO2002078648A3 Topical composition comprising an antifungal |
| 12/11/2003 | WO2002067986A3 Symbiotic regenerative agent |
| 12/11/2003 | WO2002065943A3 Ocular tear growth factor-like protein |
| 12/11/2003 | WO2002048165A8 Antiviral agents for treatment of flaviviridae infections |
| 12/11/2003 | WO2002046212A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/11/2003 | WO2002041884A8 Inhibitors of abc drug transporters at the blood-brain barrier |
| 12/11/2003 | US20030229226 Cathepsin cysteine protease inhibitors |
| 12/11/2003 | US20030229220 Oligomer phosphoramidite compositions and processes for synthesizing the same |
| 12/11/2003 | US20030229217 Comprises gamma-amino butyric acid (GABA) receptor subunits for treatment of obesity, vision defects, high blood pressure, depression and sexual disorders |
| 12/11/2003 | US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders |
| 12/11/2003 | US20030229202 Comprises fusion protein for intracelluar delivery of compounds of interest into cells; drug delivery |
| 12/11/2003 | US20030229200 Useful in treating or preventing obesity |
| 12/11/2003 | US20030229199 Modulator comprising cyclic peptide for use in treatment of cancer, gastrointestinal, inflammatory and nervous system disordrers |
| 12/11/2003 | US20030229143 Use of a retinoid type compound to modulate in vivo the decoupling activity of the protein UCP2 |
| 12/11/2003 | US20030229138 Aza hydroxylated ethyl amine compounds utility |
| 12/11/2003 | US20030229134 Methods for stimulating nervous system regeneration and repair by inhibiting phosphodiesterase type 4 |
| 12/11/2003 | US20030229133 Amidine inhibitors of serine proteases |
| 12/11/2003 | US20030229130 Imidazolinylmethyl aralkylsulfonamides |
| 12/11/2003 | US20030229127 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 12/11/2003 | US20030229124 Lipid peroxide-lowering compositions |
| 12/11/2003 | US20030229118 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 12/11/2003 | US20030229116 Enamine derivatives |
| 12/11/2003 | US20030229110 Cell signal transduction |
| 12/11/2003 | US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 12/11/2003 | US20030229108 Angiogenesis inhibitors; antitumor agents, anticancer agents |
| 12/11/2003 | US20030229102 Sulfonamide derivatives |
| 12/11/2003 | US20030229100 Anticholesterol agents; antidiabetic agents; hypotensive agents |
| 12/11/2003 | US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 12/11/2003 | US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 12/11/2003 | US20030229080 Cardiovascular disorders; sexual disorders |
| 12/11/2003 | US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 12/11/2003 | US20030229074 Metabolism; eating disorders; sexual disorders |
| 12/11/2003 | US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents |
| 12/11/2003 | US20030229070 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonist and alpha-1-blocking action |
| 12/11/2003 | US20030229069 1-Sulfonyl-4-aminoalkoxy indole derivatives and uses thereof |
| 12/11/2003 | US20030229068 Controlling apoptosis, cell proliferation; strokes; anticancer agents; central nervous system disorders |
| 12/11/2003 | US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents |
| 12/11/2003 | US20030229064 Method of treating cancer using dithiocarbamate derivatives |
| 12/11/2003 | US20030229057 Continuous sulfatase inhibiting progestogen hormone replacement therapy |
| 12/11/2003 | US20030229054 Novel amines as pharmaceutical agents |
| 12/11/2003 | US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/11/2003 | US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders |
| 12/11/2003 | US20030229047 Liquid formulation of decitabine and use of the same |
| 12/11/2003 | US20030229039 Gene therapy; mutant Dna |
| 12/11/2003 | US20030229034 Drug delivery; nucleic acids; complexing |
| 12/11/2003 | US20030229031 13-Methyl erythromycin derivatives |
| 12/11/2003 | US20030228653 Novel orphan cytokine receptor polypeptides |
| 12/11/2003 | US20030228625 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 12/11/2003 | US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 12/11/2003 | US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents |
| 12/11/2003 | US20030228573 Contacting test compound with Gag283 and determining its ability to bind to the apical cleft near the C-terminal domain; use in treatment of Acquired Immunodeficiency Syndrome (AIDS) |
| 12/11/2003 | US20030228384 Composition and method for the treatment of personal odors |
| 12/11/2003 | US20030228371 Anti-infarction molecules |
| 12/11/2003 | US20030228365 Pharmaceutical formulation |
| 12/11/2003 | US20030228360 Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 12/11/2003 | US20030228359 Antiallergen mixture |
| 12/11/2003 | US20030228353 Wound heraling agents; polypeptide |
| 12/11/2003 | US20030228281 Use of mutant herpes viruses and anticancer agents in the treatment of cancer |
| 12/11/2003 | US20030228275 Immobilization of drugs |
| 12/11/2003 | CA2706635A1 Camptothecins with a modified lactone ring |
| 12/11/2003 | CA2488270A1 Paramyxoviral vectors encoding antibodies, and uses thereof |
| 12/11/2003 | CA2488048A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | CA2488013A1 Methods of using jnk or mkk inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 12/11/2003 | CA2488012A1 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | CA2487923A1 Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (cox 2) inhibitor(s) |
| 12/11/2003 | CA2487885A1 Amyotrophic lateral sclerosis treatment with cyclooxygenase-2 inhibitors |
| 12/11/2003 | CA2487757A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue |
| 12/11/2003 | CA2487730A1 Sgk and nedd used as diagnostic and therapeutic targets |
| 12/11/2003 | CA2487688A1 Piperidine derivative, process for producing the same, and use |
| 12/11/2003 | CA2487679A1 Inhibitors of jak and cdk2 protein kinases |
| 12/11/2003 | CA2487675A1 Novel substituted indoles |
| 12/11/2003 | CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 12/11/2003 | CA2487585A1 Formulations for amylin agonist peptides |
| 12/11/2003 | CA2487509A1 New salts |
| 12/11/2003 | CA2486933A1 Tetrahydropyran derivative |
| 12/11/2003 | CA2486832A1 Pyranoindazoles and their use for the treatment of glaucoma |
| 12/11/2003 | CA2486530A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 12/11/2003 | CA2485111A1 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 12/11/2003 | CA2484626A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
| 12/11/2003 | CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/11/2003 | CA2483145A1 Transgenic plants with controlled distribution of a trait to progeny |
| 12/11/2003 | CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound |